Étude de l'expression de l'ARNm de l'interleukine-17 dans les lavages broncho-alvéolaires des chevaux atteints du souffle

Mémoire numérisé par la Direction des bibliothèques de l'Université de Montréal.

Étude de l'expression de l'ARNm de l'interleukine-17 dans les lavages broncho-alvéolaires des chevaux atteints du souffle

Mémoire numérisé par la Direction des bibliothèques de l'Université de Montréal.

Fibrose pulmonaire idiopathique

SCOPUS: ar.j

La place de la chimiothérapie dans le traitement du cancer broncho pulmonaire

SCOPUS: ar.j

Dissémination extra-pulmonaire - vers de nouveaux vaccins et outils diagnostiques de la tuberculose

info:eu-repo/semantics/published

Diagnostic d'embolie pulmonaire: problématique résiduelle des D-dimères faussement positifs [The unresolved issue of false-positive D-dimer results in the diagnostic workup of pulmonary embolism].

The unresolved issue of false-positive D-dimer results in the diagnostic workup of pulmonary embolism Pulmonary embolism (PE) remains a difficult diagnosis as it lacks specific symptoms and clinical signs. After the determination of the pretest PE probability by a validated clinical score, D-dimers (DD) is the initial blood test in the majority of patients whose probability is low or intermediate. The low specificity of DD results in a high number of false-positives that then require thoracic angio-CT. A new clinical decision rule, called the Pulmonary Embolism Rule-out criteria (PERC), identifies patients at such low risk that PE can be safely ruled-out without a DD test. Its safety has been confirmed in US emergency departments, but retrospective European studies showed that it would lead to 5-7% of undiagnosed PE. Alternative strategies are needed to reduce the proportion of false-positive DD results.

Le nodule pulmonaire solitaire [The solitary pulmonary nodule]

The incidental discovery of a solitary pulmonary nodule while performing a CT scan of the chest is a very common clinical problem. The differential diagnosis is large but the main clinical challenge is to exclude or ascertain a neoplasia. The evaluation of preexisting risk factors and the analysis of morphological characteristics of the nodule allow the clinician to solve this challenge in a significant number of cases. When the nature of the lesion remains indeterminate a careful follow-up with volumetric determination is necessary for decision making.